Non-linear association of periodontal pathogen antibodies with mortality
- Damian Sanchez-Torres,
- Dayro Gutierrez-Bejarano,
- ,
- Pilar Guallar-Castillon,
- Paul Muntner,
- Martin Laclaustra(corresponding author)
- Centro Nacional de Investigaciones Cardiovasculares Carlos III,
- ,
- Universidad Autónoma de Madrid,
- The University of Alabama at Birmingham,
- St. Louis University
Publication Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 628-636 (9 pages)Journal (Volume, Issue Number)
International Journal of Cardiology (Volume 187, Issue 1)Publication milestones
- Published - 06/05/2015
Publication status
ISSN
0167-5273Publication IDs
- Scopus: 84929159673
- PubMed: 25863738
Abstract
Background: Periodontal pathogens are associated with predisposition to chronic diseases and death. Antibody levels against them reflect flora burden, although high levels might indicate a protective response. We studied all-cause and cause specific mortality in relation to antibody levels in a representative US sample. Methods: Adults ≥20 years (n=6993) from the second phase of the Third National Health and Nutrition Examination Survey (NHANES III) were followed for a median of 13.2 years. Serum antibodies against Porphyromonas gingivalis (antiPG) and Actinobacillus actinomycetemcomitans (antiAA) were quantified by ELISA at baseline (1991-1994). Mortality hazard ratios (HRs) were calculated across antibody quartiles using the quartile with highest mortality as reference. Results: Median (25th, 75th percentiles) antiPG was 72 (63, 93) ELISA Units (EU) and median antiAA was 70 (64, 89) EU. After adjustment for potential confounders, mortality was highest for participants with antibodies in the third antiPG quartile (72-92 EU), with lower mortality risk for values not only below but also above this range [HR for the 1st to 4th quartiles: 0.81 (95% CI: 0.65, 1.01), 0.67 (95% CI: 0.55, 0.82), 1.00 (Reference), 0.79 (95% CI: 0.64, 0.97)]. In spline regression models the association had an inverted U-shape and mortality exhibited a peak at 84 EU (67th percentile). Mortality was not associated with antiAA. Conclusions: Mortality was highest for those just above the median antiPG and a reduced risk was present among those with lowor high levels of the antibody. Future studies should confirm this downward trend in upper levels and investigate a potential protective role of immunity against P. gingivalis.
